X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs SANOFI INDIA - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. SANOFI INDIA WOCKHARDT LTD./
SANOFI INDIA
 
P/E (TTM) x -11.2 34.3 - View Chart
P/BV x 2.2 6.9 32.4% View Chart
Dividend Yield % 1.5 1.3 112.8%  

Financials

 WOCKHARDT LTD.   SANOFI INDIA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
SANOFI INDIA
Dec-16
WOCKHARDT LTD./
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,1294,560 24.8%   
Low Rs6274,400 14.3%   
Sales per share (Unadj.) Rs363.11,028.5 35.3%  
Earnings per share (Unadj.) Rs-20.4129.0 -15.9%  
Cash flow per share (Unadj.) Rs-7.0186.0 -3.8%  
Dividends per share (Unadj.) Rs10.0068.00 14.7%  
Dividend yield (eoy) %1.11.5 75.0%  
Book value per share (Unadj.) Rs301.8753.6 40.1%  
Shares outstanding (eoy) m110.5523.03 480.0%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.44.4 55.5%   
Avg P/E ratio x-42.934.7 -123.6%  
P/CF ratio (eoy) x-125.924.1 -522.5%  
Price / Book Value ratio x2.95.9 48.9%  
Dividend payout %-48.952.7 -92.8%   
Avg Mkt Cap Rs m97,063103,174 94.1%   
No. of employees `0006.83.6 186.8%   
Total wages/salary Rs m9,6653,592 269.1%   
Avg. sales/employee Rs Th5,931.86,537.7 90.7%   
Avg. wages/employee Rs Th1,428.1991.4 144.0%   
Avg. net profit/employee Rs Th-334.0819.8 -40.7%   
INCOME DATA
Net Sales Rs m40,14623,686 169.5%  
Other income Rs m1,143708 161.4%   
Total revenues Rs m41,28924,394 169.3%   
Gross profit Rs m1285,281 2.4%  
Depreciation Rs m1,4891,313 113.4%   
Interest Rs m2,25315 15,018.0%   
Profit before tax Rs m-2,4724,661 -53.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2111,691 -12.5%   
Profit after tax Rs m-2,2602,970 -76.1%  
Gross profit margin %0.322.3 1.4%  
Effective tax rate %8.536.3 23.5%   
Net profit margin %-5.612.5 -44.9%  
BALANCE SHEET DATA
Current assets Rs m46,16015,673 294.5%   
Current liabilities Rs m19,2586,678 288.4%   
Net working cap to sales %67.038.0 176.5%  
Current ratio x2.42.3 102.1%  
Inventory Days Days10176 132.6%  
Debtors Days Days9422 421.5%  
Net fixed assets Rs m40,1658,098 496.0%   
Share capital Rs m553230 240.0%   
"Free" reserves Rs m32,81417,088 192.0%   
Net worth Rs m33,36717,356 192.3%   
Long term debt Rs m31,9030-   
Total assets Rs m89,68725,400 353.1%  
Interest coverage x-0.1311.7 -0.0%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.40.9 48.0%   
Return on assets %011.8 -0.1%  
Return on equity %-6.817.1 -39.6%  
Return on capital %-0.326.9 -1.2%  
Exports to sales %024.5 0.0%   
Imports to sales %028.0 0.0%   
Exports (fob) Rs mNA5,801 0.0%   
Imports (cif) Rs mNA6,627 0.0%   
Fx inflow Rs m9,1217,145 127.7%   
Fx outflow Rs m2,1336,846 31.2%   
Net fx Rs m6,988299 2,337.0%   
CASH FLOW
From Operations Rs m-2,6953,226 -83.5%  
From Investments Rs m-6,863-1,555 441.3%  
From Financial Activity Rs m12,545-1,818 -690.0%  
Net Cashflow Rs m3,010-147 -2,047.8%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 2.3 14.4 16.0%  
FIIs % 7.7 14.6 52.7%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 10.5 146.7%  
Shareholders   67,757 15,184 446.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   STERLING BIOTECH  NOVARTIS  ALEMBIC PHARMA  ORCHID PHARMA LTD  PFIZER  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jun 22, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - AJANTA PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS